Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
Jingjing Deng, Mei Zhou, Tingting Liao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma
Shun Wang, Zhu Le, Tianen Li, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101415-101415
Open Access | Times Cited: 26
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy
Ryungsa Kim, Takanori Kin, William T. Beck
Cancers (2024) Vol. 16, Iss. 5, pp. 984-984
Open Access | Times Cited: 21
Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: a comprehensive review
Manjusha Bhange, Darshan R. Telange
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Ferroptosis and its interaction with tumor immune microenvironment in liver cancer
Yilan Huang, Siwei Wang, Ai‐Wu Ke, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188848-188848
Closed Access | Times Cited: 47
Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy
Rui Wang, Wenqin Song, Jie Zhu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 84-96
Closed Access | Times Cited: 14
Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy
Li Yu, Ke Huang, Yixiang Liao, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 13
Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment
Haojie Wang, Yuanyuan Xie
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 334-334
Open Access | Times Cited: 1
Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
Chuansheng Yang, Zhikai Mai, Can Liu, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3513-3513
Open Access | Times Cited: 29
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment
Zhaoshi Bai, Yiran Zhou, Yaling Peng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188965-188965
Closed Access | Times Cited: 19
Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy – Significance for cancer treatment?
Mateusz Kciuk, Adrianna Gielecińska, Żaneta Kałuzińska‐Kołat, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189124-189124
Open Access | Times Cited: 8
The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance
Anqi Chen, Wenjie Zhang, Chuwen Jiang, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 1, pp. 7-18
Closed Access | Times Cited: 5
Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials
Pawan Kumar Pandey, Saurabh Bhorkade, Shikha Jha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105998-105998
Closed Access | Times Cited: 5
Ferroptosis resistance in cancer: recent advances and future perspectives
Zhang Xing, Xiang Li, Xia Ran, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115933-115933
Closed Access | Times Cited: 11
Targeting Ferroptosis as an Advance Strategy in Cancer Therapy
Tobias Achu Muluh, Qianqian Fu, Xiaojiao Ai, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 10-12, pp. 616-636
Closed Access | Times Cited: 4
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis Sensitivity
Che-Pei Kung, Nick Terzich, Ma Xenia G. Ilagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The role of ferroptosis in breast cancer: tumor progression, immune microenvironment interactions and therapeutic interventions
Yiping Wang, Chuanyun Tang, Keqin Wang, et al.
European Journal of Pharmacology (2025) Vol. 996, pp. 177561-177561
Closed Access
Lipid acid metabolism reprogramming nanoagent induces ferroptosis storm and cGAS-STING activation for metal-immunotherapy of triple negative breast cancer
Dawei Zhou, Gaorui Zhang, J. Zhu, et al.
Chemical Engineering Journal (2025), pp. 162048-162048
Closed Access
Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody
Qimeng Chang, Huarong Mao, Jin-Feng Feng, et al.
Biochemical Pharmacology (2025), pp. 116927-116927
Closed Access
Current advances on the role of ferroptosis in tumor immune evasion
Chunfang Gao, Haoran Zhang, Xianwei Wang
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Myeloid effector cells in cancer
Pieter J. Schol, Marit J. van Elsas, Jim Middelburg, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 1997-2014
Closed Access | Times Cited: 3
Reconnoitering the role of Lipid Metabolites in Ferroptosis
Manikandan Vani Raju, Meenakshi Kaniyur Chandrasekaran, Rathi Muthaiyan Ahalliya, et al.
Advances in Redox Research (2024) Vol. 14, pp. 100117-100117
Closed Access | Times Cited: 3
The Impact of Iron on Cancer-Related Immune Functions in Oncology: Molecular Mechanisms and Clinical Evidence
Omar Badran, Idan Cohen, Gil Bar‐Sela
Cancers (2024) Vol. 16, Iss. 24, pp. 4156-4156
Open Access | Times Cited: 3
The recent advancements of ferroptosis of gynecological cancer
Shenglan Tang, Li Chen
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer
Xueyan Shi, Sichong Han, Guizhen Wang, et al.
Frontiers of Medicine (2024)
Closed Access | Times Cited: 2
The anticarcinogenic effect of eugenol on lung cancer induced by diethylnitrosamine/2-acetylaminofluorene in Wistar rats: insight on the mechanisms of action
Hadeer M. Morsy, Osama M. Ahmed, Khairy M. A. Zoheir, et al.
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 1184-1197
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top